Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries
Fecha
2023Autor
Urueña, Analía
Machado, Ricardo
Cunha, Juarez
López Colmano, Clara
Rancaño, Carolina
Kfouri, Renato
Pirez, Catalina
Bonhevi, Pablo
Calvo, Mario
Rodríguez, Mónica
Torres, Jaime
Chan, Florencia
Ballalai, Isabella
Metadatos
Mostrar el registro completo del ítemResumen
This article presents attitudes and practices regarding COVID-19 vaccination in the South American population. The study collected data from a self-administered survey distributed through social media platforms between February and April 2022 (N = 6555). The survey included questions related to participants’ sociodemographic background, flu vaccination practices, sources of information about COVID-19, and opinions regarding pandemic management and vaccination against SARS-CoV-2. The respondents agreed with the statement that COVID-19 vaccines were necessary (86.4%), effective (79.8%), safe (79.1%), and should be mandatory (64%). Overall, 83.4% accepted vaccination and 12.3% refused it completely. Main rejection reasons were safety (65.8%) and efficacy (54.9%) issues, and rushed development and approvals (49.1%). Vaccine uptake was associated with being ≥60 years, being a healthcare worker, previous influenza vaccine uptake, adherence to preventive measures, the death of ≥1 close people from COVID-19, and being informed through mass media or health authorities’ channels. Vaccine uptake inversely correlated with male gender, low educational level, and use of closed social networks for COVID-19 information purposes. This study provides valuable insights into COVID-19 vaccination attitudes and practices in South America that may be used to promote vaccine uptake in the region. Higher COVID-19 vaccination acceptance among people with previously acquired prevention habits reinforces the importance of routine health promotion strategies.
URI
https://www.mdpi.com/2076-393X/11/11/1660http://repositorio.isalud.edu.ar/xmlui/handle/123456789/2041
https://doi.org/10.3390/vaccines11111660